Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:714-720

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vohl, M.-C.
Right arrow Articles by Després, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vohl, M.-C.
Right arrow Articles by Després, J.-P.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:714-720.)
© 1995 American Heart Association, Inc.


Articles

The Lipoprotein Lipase HindIII Polymorphism Modulates Plasma Triglyceride Levels in Visceral Obesity

Marie-Claude Vohl; Benoît Lamarche; Sital Moorjani; Denis Prud'homme; André Nadeau; Claude Bouchard; Paul-J. Lupien; Jean-Pierre Després

From the Lipid Research Center, CHUL Research Center (M.-C.V., B.L., S.M., P.-J.L., J.-P.D.), the Physical Activity Sciences Laboratory (D.P., C.B.), and the Diabetes Research Unit, CHUL Research Center (A.N.), Laval University, Ste-Foy, Québec.

Correspondence to Dr Jean-Pierre Després, Lipid Research Center CHUL, 2705 Laurier Blvd, Québec, GIV 4G2, Canada.

Abstract The aim of this study was to investigate the potential interaction between the lipoprotein lipase (LPL) HindIII polymorphism and visceral adipose tissue (AT) accumulation in the modulation of triglyceride levels in visceral obesity. The LPL-HindIII genotype was determined by polymerase chain reaction in 52 men. Twenty-three subjects were heterozygous (+/-) and 28 were homozygous (+/+) for the presence of the restriction site. One subject who was homozygous for the - allele was excluded from analysis. Body mass index (BMI), fasting insulin level, and visceral AT area as measured by computed tomography were positively correlated with triglyceride levels only in subjects homozygous for the + allele. Furthermore, whereas these variables were negatively correlated with plasma HDL2 cholesterol concentrations in the +/+ group, these associations were not found in +/- heterozygotes, with the exception of BMI. To further investigate the interaction of the LPL-HindIII polymorphism with visceral obesity and hyperinsulinemia, the two genotype groups were further subdivided on the basis of BMI (low versus high), fasting insulin level (low versus high), and visceral AT area (low versus high), and their lipoprotein profiles were compared. Elevated levels of abdominal visceral AT were significantly associated with increased triglyceride concentrations in +/+ homozygous men, suggesting that visceral obesity may lead to hypertriglyceridemia in the presence of the +/+ genotype. In the +/- group, variation in the amount of visceral AT was not associated with differences in triglyceride concentration. However, hypertriglyceridemia and an increased cholesterol-to–HDL cholesterol ratio were observed in the hyperinsulinemic state irrespective of LPL-HindIII genotype status. Finally, similar positive correlations were observed between visceral AT accumulation and plasma insulin level in the homozygous (+/+) and heterozygous (+/-) groups, suggesting that the hyperinsulinemic–insulin-resistant state that is frequently associated with visceral obesity is independent of LPL-HindIII genotype. These results suggest that the HindIII polymorphism may modulate the magnitude of the dyslipidemic state associated with visceral obesity.


Key Words: lipoprotein lipase • visceral obesity • insulin • hypertriglyceridemia • candidate genes




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
G. S. Sagoo, I. Tatt, G. Salanti, A. S. Butterworth, N. Sarwar, M. van Maarle, J. W. Jukema, B. Wiman, J. J. P. Kastelein, A. M. Bennet, et al.
Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis
Am. J. Epidemiol., December 1, 2008; 168(11): 1233 - 1246.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Lopez-Miranda, G. Cruz, P. Gomez, C. MarIn, E. Paz, P. Perez-MartInez, F. J. Fuentes, J. M. Ordovas, and F. Perez-Jimenez
The Influence of Lipoprotein Lipase Gene Variation on Postprandial Lipoprotein Metabolism
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4721 - 4728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Perusse and C. Bouchard
Gene-diet interactions in obesity
Am. J. Clinical Nutrition, November 1, 2000; 72 (5): 1285S - 1290S.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Larson, M. M. Hoffmann, J. M. Ordovas, E. J. Schaefer, W. Marz, and J. Kreuzer
The Lipoprotein Lipase HindIII Polymorphism: Association with Total Cholesterol and LDL-Cholesterol, but not with HDL and Triglycerides in 342 Females
Clin. Chem., July 1, 1999; 45(7): 963 - 968.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Rönnemaa, J. Marniemi, M. J. Savolainen, Y. A. Kesäniemi, C. Ehnholm, C. Bouchard, and M. Koskenvuo
Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2792 - 2799.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. M. Dong, J.-C. Gutierrez-Ramos, A. Coxon, T. N. Mayadas, and D. D. Wagner
A new class of obesity genes encodes leukocyte adhesion receptors
PNAS, July 8, 1997; 94(14): 7526 - 7530.
[Abstract] [Full Text] [PDF]